Anxiety Disorders Completed Phase 1 Trials for Escitalopram (DB01175)

Also known as: Anxiety Disorder / Anxiety NOS

IndicationStatusPhase
DBCOND0027904 (Anxiety Disorders)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01745601Bioequivalence Study of Escitalopram Tablets 10 mgOther